特刊社论：“耐药菌引起的细菌和真菌感染的当前及新型抗菌策略”
Editorial for the Special Issue: "Current and Novel Antimicrobial Strategies for Bacterial and Fungal Infections by Resistant Organisms".
作者信息
Maraolo Alberto Enrico
机构信息
First Division of Infectious Diseases, Cotugno Hospital, AORN Ospedali dei Colli, 80131 Naples, Italy.
出版信息
Antibiotics (Basel). 2022 Mar 23;11(4):426. doi: 10.3390/antibiotics11040426.
Abstract
The pandemic driven by the SARS-CoV-2 infection has compelled health services globally to direct all available human and economic resources toward fighting the novel coronavirus [...].
摘要
由严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染引发的大流行迫使全球卫生服务机构将所有可用的人力和经济资源用于抗击新型冠状病毒[……]。
相似文献
1
Editorial for the Special Issue: "Current and Novel Antimicrobial Strategies for Bacterial and Fungal Infections by Resistant Organisms".特刊社论：“耐药菌引起的细菌和真菌感染的当前及新型抗菌策略”
Antibiotics (Basel). 2022 Mar 23;11(4):426. doi: 10.3390/antibiotics11040426.
2
State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia.COVID-19 肺炎患者继发肺部感染的研究进展。
Infection. 2021 Aug;49(4):591-605. doi: 10.1007/s15010-021-01602-z. Epub 2021 Mar 11.
3
The report from ASFA COVID-19 taskforce: Considerations and prioritization on apheresis procedures during the SARS-CoV-2 coronavirus disease (COVID-19) pandemic.ASFA COVID-19 工作组的报告：在 SARS-CoV-2 冠状病毒病（COVID-19）大流行期间对血浆分离术程序的考虑和优先级排序。
J Clin Apher. 2021 Dec;36(6):878-881. doi: 10.1002/jca.21939. Epub 2021 Sep 12.
4
Evaluating the Antimicrobial Properties of Commercial Hand Sanitizers.评估市售手部消毒剂的抗菌性能。
mSphere. 2021 Mar 3;6(2):e00062-21. doi: 10.1128/mSphere.00062-21.
5
Human and novel coronavirus infections in children: a review.儿童人感染和新型冠状病毒感染：综述。
Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25.
6
Shedding Light on the Effect of Natural Anti-Herpesvirus Alkaloids on SARS-CoV-2: A Treatment Option for COVID-19.揭示天然抗疱疹生物碱对 SARS-CoV-2 的影响：COVID-19 的一种治疗选择。
Viruses. 2020 Apr 23;12(4):476. doi: 10.3390/v12040476.
7
Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting.COVID-19 住院患者的细菌和真菌感染：英国二级保健机构中的回顾性队列研究。
Clin Microbiol Infect. 2020 Oct;26(10):1395-1399. doi: 10.1016/j.cmi.2020.06.025. Epub 2020 Jun 27.
8
Bacterial Epidemiology and Antimicrobial Resistance Profiles in Children Reported by the ISPED Program in China, 2016 to 2020.中国 ISPED 项目报告的 2016 至 2020 年儿童细菌流行病学和抗菌药物耐药性特征。
Microbiol Spectr. 2021 Dec 22;9(3):e0028321. doi: 10.1128/Spectrum.00283-21. Epub 2021 Nov 3.
9
Fighting the Coronavirus disease (Covid-19) pandemic: Employing lessons from the Ebola virus disease response.抗击冠状病毒病（COVID-19）大流行：借鉴埃博拉病毒病应对经验
Ethics Med Public Health. 2020 Oct-Dec;15:100558. doi: 10.1016/j.jemep.2020.100558. Epub 2020 Jul 3.
10
Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.基于 SARS-CoV-2 的免疫原性结构蛋白、宿主免疫反应和群体免疫的 COVID-19 疫苗开发的新见解。
Cells. 2021 Oct 29;10(11):2949. doi: 10.3390/cells10112949.
本文引用的文献
1
Oral Vancomycin Prophylaxis for Primary and Secondary Prevention of Infection in Patients Treated with Systemic Antibiotic Therapy: A Systematic Review, Meta-Analysis and Trial Sequential Analysis.口服万古霉素用于全身抗生素治疗患者感染的一级和二级预防：系统评价、荟萃分析和试验序贯分析
Antibiotics (Basel). 2022 Jan 30;11(2):183. doi: 10.3390/antibiotics11020183.
2
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.2019 年全球细菌对抗菌药物耐药性的负担：系统分析。
Lancet. 2022 Feb 12;399(10325):629-655. doi: 10.1016/S0140-6736(21)02724-0. Epub 2022 Jan 19.
3
Early Diagnosis and Antibiotic Treatment Combined with Multicomponent Hemodynamic Support for Addressing a Severe Case of Lemierre's Syndrome.早期诊断、抗生素治疗联合多组分血流动力学支持治疗1例严重的勒米尔综合征
Antibiotics (Basel). 2021 Dec 14;10(12):1526. doi: 10.3390/antibiotics10121526.
4
Perspectives of Healthcare Professionals Regarding Factors Associated with Antimicrobial Resistance (AMR) and Their Consequences: A Cross Sectional Study in Eastern Province of Saudi Arabia.医疗保健专业人员对抗菌药物耐药性（AMR）相关因素及其后果的看法：沙特阿拉伯东部省份的横断面研究
Antibiotics (Basel). 2021 Jul 19;10(7):878. doi: 10.3390/antibiotics10070878.
5
Use of Ceftaroline in Hospitalized Patients with and without COVID-19: A Descriptive Cross-Sectional Study.头孢洛林在合并及未合并新型冠状病毒肺炎的住院患者中的应用：一项描述性横断面研究。
Antibiotics (Basel). 2021 Jun 23;10(7):763. doi: 10.3390/antibiotics10070763.
6
Cefiderocol-Based Combination Therapy for "Difficult-to-Treat" Gram-Negative Severe Infections: Real-Life Case Series and Future Perspectives.基于头孢地尔的联合疗法治疗“难治性”革兰氏阴性菌严重感染：真实病例系列及未来展望
Antibiotics (Basel). 2021 May 29;10(6):652. doi: 10.3390/antibiotics10060652.
7
Existence of Multiple ESBL Genes among Phenotypically Confirmed ESBL Producing and Concurrently Isolated from Clinical, Colonization and Contamination Samples from Neonatal Units at Bugando Medical Center, Mwanza, Tanzania.在坦桑尼亚姆万扎布甘多医疗中心新生儿病房的临床、定植和污染样本中，从表型确认产超广谱β-内酰胺酶（ESBL）且同时分离出的菌株中存在多种ESBL基因。
Antibiotics (Basel). 2021 Apr 21;10(5):476. doi: 10.3390/antibiotics10050476.
8
Bacteriocin-Like Inhibitory Substances from Probiotics as Therapeutic Agents for Vulvovaginitis.来自益生菌的类细菌素抑制物质作为外阴阴道炎的治疗剂
Antibiotics (Basel). 2021 Mar 17;10(3):306. doi: 10.3390/antibiotics10030306.
9
Carbapenem-sparing strategy: carbapenemase, treatment, and stewardship.碳青霉烯类药物节约策略：碳青霉烯酶、治疗和管理。
Curr Opin Infect Dis. 2019 Dec;32(6):663-673. doi: 10.1097/QCO.0000000000000598.
10
Use of colistin in adult patients: A cross-sectional study.成人患者中多黏菌素的使用：一项横断面研究。
J Glob Antimicrob Resist. 2020 Mar;20:43-49. doi: 10.1016/j.jgar.2019.06.009. Epub 2019 Jun 15.
Zotero 插件